Medical researchers have sounded fresh alarms regarding popular weight-loss and diabetes medications, revealing a tangible link between GLP-1 receptor agonists like Wegovy, Ozempic, and Mounjaro and an increased risk of sudden hair loss.
A landmark study analysing electronic patient data from roughly 50,000 adults at the University of Pennsylvania Health System has strengthened long-standing safety signals monitored by regulators in both the United Kingdom and the United States.
